49,741 XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Anabella Villalobos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Ann Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Dieter Weinand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Wilbur L. Ross | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Dov A. Goldstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Howard Berman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 150,602 | 150,602 | - | - | Stock Option (right to buy) | |
| Arun Swaminathan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 240,964 | 240,964 | - | - | Stock Option (right to buy) | |
| Fred Grossman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 140,562 | 140,562 | - | - | Stock Option (right to buy) | |
| David S. Snyder | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 140,562 | 140,562 | - | - | Stock Option (right to buy) | |
| Ann Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Dov A. Goldstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Wilbur L. Ross | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Dieter Weinand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Anabella Villalobos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| David S. Snyder | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 7.19 per share. | 14 Nov 2024 | 1,800 | 8,800 | - | 7.2 | 12,934 | Common Stock, par value $0.0001 per share |
| Arun Swaminathan | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 7.36 per share. | 13 Nov 2024 | 5,000 | 10,000 | - | 7.4 | 36,797 | Common Stock, par value $0.0001 per share |
| Arun Swaminathan | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 7.34 per share. | 11 Nov 2024 | 5,000 | 5,000 | - | 7.3 | 36,689 | Common Stock, par value $0.0001 per share |
| Fred Grossman | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 7.37 per share. | 11 Nov 2024 | 2,710 | 2,710 | - | 7.4 | 19,973 | Common Stock, par value $0.0001 per share |
| Howard Berman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 163,663 | 163,663 | - | - | Stock Option (right to buy) | |
| Fred Grossman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 70,596 | 70,596 | - | - | Stock Option (right to buy) | |
| David S. Snyder | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 70,596 | 70,596 | - | - | Stock Option (right to buy) | |
| Snyder David S. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2024 | 81,819 | 81,819 | - | - | Stock Option (right to buy) | |
| Fred Grossman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 74,069 | 74,069 | - | - | Stock Option (right to buy) | |
| Grossman Fred | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 81,819 | 81,819 | - | - | Stock Option (right to buy) | |
| Berman Howard | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 189,680 | 189,680 | - | - | Stock Option (right to buy) | |
| Ross Wilbur L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Villalobos Anabella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Ann Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Garren Hideki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Dieter Weinand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| A. Dov Goldstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Ann Lee | Director | Purchase of securities on an exchange or from another person at price $ 3.62 per share. | 22 Aug 2023 | 1,000 | 17,479 | - | 3.6 | 3,620 | Common Stock, par value $0.0001 per share |
| Dieter Weinand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2023 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Fred Grossman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 74,069 | 74,069 | - | - | Stock Option (right to buy) | |
| Adrian Hepner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 115,000 | 115,000 | - | - | Stock Option (right to buy) | |
| David S. Snyder | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 115,000 | 115,000 | - | - | Stock Option (right to buy) | |
| Howard Berman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 165,000 | 165,000 | - | - | Stock Option (right to buy) | |
| Hideki Garren | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2023 | 1,000 | 1,000 | - | - | Warrant to Purchase Common Stock | |
| Dov A. Goldstein | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2023 | 5,000 | 5,000 | - | - | Warrant to Purchase Common Stock | |
| Dov A. Goldstein | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2023 | 10,000 | 10,000 | - | - | Common Stock, par value $0.0001 per share | |
| Adrian Hepner | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2023 | 10,000 | 10,000 | - | - | Common Stock, par value $0.0001 per share | |
| Adrian Hepner | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2023 | 5,000 | 5,000 | - | - | Warrant to Purchase Common Stock | |
| David S. Snyder | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2023 | 7,000 | 7,000 | - | - | Common Stock, par value $0.0001 per share | |
| David S. Snyder | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2023 | 3,500 | 3,500 | - | - | Warrant to Purchase Common Stock | |
| Hideki Garren | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2023 | 2,000 | 2,000 | - | - | Common Stock, par value $0.0001 per share | |
| Anabella Villalobos | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2023 | 5,000 | 5,000 | - | - | Warrant to Purchase Common Stock | |
| Anabella Villalobos | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2023 | 10,000 | 10,000 | - | - | Common Stock, par value $0.0001 per share | |
| Ann Lee | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2022 | 10,000 | 10,000 | - | - | Common Stock, par value $0.0001 per share | |
| Ann Lee | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2022 | 5,000 | 9,479 | - | - | Warrant to Purchase Common Stock | |
| Ann Lee | Director | 03 Jan 2022 | 6,479 | 16,479 | - | 4 | 25,916 | Common Stock, par value $0.0001 per share |